Skip to main content

Table 2 Demographic and clinical characteristics of the 147 included patients

From: Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study

Variable n (%) or mean ± SD
Sex, males 112 (76.2)
Age, years 65.4 (10.6)
BMI, kg/m2 26.4 (4.1)
(Previous) smoker 68 (46.3)
Hypertension 79 (53.7)
Diabetes mellitus 16 (10.9)
 Nephrostomy catheter 14 (10.1)
ASA class
 ASA class 1 20 (13.6)
 ASA class 2 91 (61.9)
 ASA class 3 36 (24.5)
Indication
 Bladder cancer 123 (81.6)
  Stage T ≥ T2 73 (59.3)
 Other malignancy 13 (8.8)
  Functional 8 (5.4)
  Other 3 (2.0)
Colonization with MDRO 7 (4.8)
Guideline-accordant prophylaxis 116 (78.9)
 Correct choice 134 (91.2)
 Correct dose 124 (92.5)
 Administration < 60 min prior to incision 142 (91.2)
Type of diversion
 Ileal conduit 120 (81.6)
 Hautmann neobladder 27 (18.4)
Duration surgery, minutes 216 (75)
Blood loss, ml 1031 (700)
  1. Abbreviations: ASA American Society of Anesthesiologists, BMI body mass index, IQR interquartile range, MDRO multidrug resistant microorganism, SD standard deviation